Intangible Assets

12 Months Ended

Oct. 31, 2014

Goodwill and Intangible Assets Disclosure [Abstract]

Goodwill



(In thousands)	CooperVision			CooperSurgical			Total
Balance as of October 31, 2012	$	1,044,054		$	326,193		$	1,370,247
Net additions during the year ended October 31, 2013	3,363			11,017			14,380
Translation	1,061			1,923			2,984
Balance as of October 31, 2013	$	1,048,478		$	339,133		$	1,387,611
Net additions during the year ended October 31, 2014	857,146			25,543			882,689
Translation	(44,063		)	(5,316		)	(49,379		)
Balance as of October 31, 2014	$	1,861,561		$	359,360		$	2,220,921

Of the October 31, 2014 goodwill balance, $76.1 million for CooperSurgical and $17.8 million for CooperVision is expected to be deductible for tax purposes.

Other Intangible Assets



	As of October 31, 2014				As of October 31, 2013
(In thousands)	Gross Carrying Amount		Accumulated Amortization & Translation		Gross Carrying Amount		Accumulated Amortization & Translation		Weighted Average Amortization Period
									(In years)
Trademarks	$	21,281	$	2,937	$	12,481	$	2,337	14
Technology	326,620		93,780		133,842		84,371		11
Customer relationships	233,246		90,704		199,379		75,700		14
License and distribution rights and other	73,479		13,600		24,947		9,472		8
	654,626		$	201,021	370,649		$	171,880	12
Less accumulated amortization and translation	201,021				171,880
Other intangible assets, net	$	453,605			$	198,769

Included in Technology for fiscal 2014 is $43.1 million of acquired in-process research and development from Sauflon that is not amortized. See Note 2 for additional information on acquired intangible assets from Sauflon.

We estimate that amortization expense for our existing other intangible assets will be $52.2 million in fiscal 2015, $49.8 million in fiscal 2016, $46.4 million in fiscal 2017, $44.4 million in fiscal 2018 and $41.6 million in fiscal 2019.